openPR Logo
Press release

Global Electrophysiology Ablation Market - Upcoming Trends, Growth Drivers and Challenges - Forecast to 2031

07-13-2022 09:54 PM CET | Health & Medicine

Press release from: Persistence Market Research

Global Electrophysiology Ablation Market - Upcoming Trends,

According to a recent study by Persistence Market Research, the global electrophysiology ablation market is expected to witness high growth from US$ 2.5 Bn in 2021 to US$ 6.3 Bn by 2031. This reflects a CAGR of around 8.4% over the forecast period (2021-2031).

Rising morbidity and mortality due to cardiac disorders, especially arrhythmia, make this market more demanding. Moreover, new product innovation and increased adoption of electrophysiology ablation devices by cardiologists in hospitals is expected to boost market growth over the forecast period.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25474

Companies

Biomerics
Biosense Webster
Abbott Laboratories
MEDTRONIC PLC
Boston Scientific Corporation
CathRx Ltd
Japan Lifeline Co
ATRICURE, INC.
Auris Health

The market is experiencing drastic changes with the high adoption of electrophysiology ablation procedures due to rising awareness about cardiac health. Sales and marketing practices by some manufacturers are influencing the procedure and device cost in selective regions. Additionally, rising investments in the healthcare sector in emerging regions and reimbursement policies for cardiac ablation are further expected to give positive growth to this market.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25474

Technological innovations are warranted to improve the safety and effectiveness of ablation devices, thereby helping market growth. Significant growth has been observed in two of the most dynamic segments: cardiac rhythm management (CRM) and electrophysiology (EP) segment, in recent years.

From the last few years, there has been considerable progress and innovation made in developing advances in heart rhythm therapy. Ongoing researches in this segment will help create the landscape for further product advancement in the electrophysiological ablation market. As the market is consolidated in terms of catheters being used, market leaders are focusing on increasing their product portfolios to strengthen their product acceptability at the end user level globally.

For instance, in June 2021, Medtronic plc received U.S. Food and Drug Administration (FDA) approval for the Arctic Front™ set of cardiac cryoablation catheters.

Leading players are focusing on investment in developing countries to increase their foothold in the market. Also, major market players have been concentrating on enhancing gains through advancements in distribution channels.

Key Takeaways from Market Study

With advanced product features and more acceptance by end users, ablation catheters hold a high market share around 47.4%.

52.5% market share is held by the atrial fibrillation (AF) segment of electrophysiology ablation, due to high prevalence of this disease and need for its treatment.

Hospitals are expected to enjoy more than half of the market share during the forecast period because of high adoption of electrophysiology ablation devices and procedures and increased number of walk-in patients.

North America market is expected to grow 2.5X over the forecast duration due to rising prevalence of conditions such as atrial fibrillation and tachycardia, growing awareness regarding cardiac health, and presence of reimbursement policies in the region.

"Increasing adoption of technologically advanced devices and growing awareness about cardiac disorder and associated risks are expected to drive demand for electrophysiology ablation over the decade," says a Persistence Market Research Analyst

Access Full Report@ https://www.persistencemarketresearch.com/checkout/25474

Who is Winning?

Major manufacturers of electrophysiology ablation devices have been focusing on product launches, collaborations, and partnerships for global expansion.

BIOTRONIK's product the Force Sensing Ablation Catheter, the first and only gold-tipped to support effective ablations in the left atrium, got CE approval in 2020.

Likewise, AtriCure got into a strategic collaboration with Baheal Group for a distribution agreement to market its products across China.

Major market players covered in the report include Biosense Webster (Johnson & Johnson), Abbott Laboratories, MEDTRONIC PLC, Boston Scientific Corporation, CathRx Ltd, Japan Lifeline Co, ATRICURE, INC., Auris Health, and Biomerics.

What Else is in the Report?

Persistence Market Research offers a unique perspective and actionable insights on electrophysiology ablation market in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021-2031, based on product (diagnostic catheters, ablation catheters, and access devices), application (supraventricular tachycardia (SVT) ablation, ventricular tachycardia(VT/VPC), and atrial fibrillation (AF)), and end user (hospitals, ambulatory surgical centers, and clinics), across seven key regions of the world.

Access PMR Exclusive Reports-

Electric Cargo Bike Market- https://www.persistencemarketresearch.com/market-research/electric-cargo-bikes-market.asp

Electric Vehicles Market- https://www.persistencemarketresearch.com/market-research/electric-vehicles-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Electrophysiology Ablation Market - Upcoming Trends, Growth Drivers and Challenges - Forecast to 2031 here

News-ID: 2679523 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for Ablation

Thyroid Ablation Devices Market
Alarming rise in prevalence of thyroid cancer, advancements in thyroid ablation system, rise in government & private funds for development of healthcare sectors, and increase in number of thyroid nodule cases are expected to notably contribute toward the growth of the global thyroid ablation devices market during the forecast period. Rise in prevalence of thyroid cancer and thyroid nodules, demand for minimally invasive procedures, and technological advancements in ablation devices drive
03-12-2021 | Health & Medicine
Fact.MR
Atrial Fibrillation (AF) Ablation Market by Procedure (Catheter Ablation, Surgic …
Arterial fibrillation is a disease that creates irregular and rapid heart rate. Atrial fibrillation ablation is performed to treat the disease. The upper chambers of the heart beat irregularly and contract randomly at a very fast rate, out of coordination with the lower ventricles of the heart due to which the time decreases for the heart muscle relaxation. This increases the rate of heart failure and heart strokes and reduces
01-21-2021 | Health & Medicine
Fact.MR
Cardiac Ablation Technologies Market
Growing acceptance of catheter ablation as the first line of therapy, along with recent developments introducing robotic catheter navigation systems and 3D electro-anatomical mapping systems creates a highly conducive environment for the growth of the cardiac ablation technologies market. However, an extensive study published by Fact.MR raises concerns regarding technical complexity leading to lack of required operational competency, which leads to fundamental barriers to the adoption of advanced ablation systems. Request
Radiofrequency Ablation Devices Market: Emerging Applications of Radiofrequency …
Radiofrequency ablation is a minimally invasive technique that uses heat and electrical energy to destroy cancer cells and other dysfunctional tissues. Recently, it has been used to treat a wide range of medical conditions. Although it is not a primary treatment of cancer, it is used to treat a spot of tumor causing pain and other medical indications. The technique is also used to treat patients suffering from adrenal gland,
Nerve Ablation Devices Market to Record an Exponential CAGR by 2028(Based on pro …
Nerves are the vital part of the body, responsible for carrying signals from different parts of the body to the brain. The nerves carry electrical signals that act on actions such as pain and other movements of the body. The nerve ablation devices are used to treat patient by minimally invasive procedures, where a microelectrode is inserted inside the patient to heat the nerve tissue. The nerve ablation devices help
Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat